nimodipine has been researched along with Dizzyness in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, C | 1 |
| Liao, L | 1 |
| Yan, X | 1 |
| Li, M | 1 |
| Wu, S | 1 |
| Wang, J | 1 |
| Lin, J | 1 |
| Li, S | 1 |
| Gao, L | 1 |
| DU, J | 1 |
| Yang, R | 1 |
1 trial available for nimodipine and Dizzyness
| Article | Year |
|---|---|
Effects of Yangxue Qingnao Granules on chronic cerebral circulation insufficiency: a randomized, double-blind, double-dummy, controlled multicentre trial.
Topics: Adult; Cerebrovascular Circulation; China; Dizziness; Dose-Response Relationship, Drug; Double-Blind | 2013 |